David Keire is acting laboratory chief, Branch I, Division of Pharmaceutical Analysis, FDA
Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?
The global supply chain for bovine and porcine heparin and regulatory considerations are examined.